BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM

Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TROLLSAS, Olof Mikael, STANKUS, John J, GHOLAMI, Shahram Shawn
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TROLLSAS, Olof Mikael
STANKUS, John J
GHOLAMI, Shahram Shawn
description Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 15 and 1,000 Centipoise per unit area.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4469108A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4469108A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4469108A13</originalsourceid><addsrcrecordid>eNrjZNB1cvXzdPdTCAjyDw5xDPF0VvCIDHANCvBxDPZ0VAgJcnUM8XX1C1EIjgwOcfXlYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmJmaWhgYWjobGRCgBAKEbJYM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM</title><source>esp@cenet</source><creator>TROLLSAS, Olof Mikael ; STANKUS, John J ; GHOLAMI, Shahram Shawn</creator><creatorcontrib>TROLLSAS, Olof Mikael ; STANKUS, John J ; GHOLAMI, Shahram Shawn</creatorcontrib><description>Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 15 and 1,000 Centipoise per unit area.</description><language>eng ; fre ; ger</language><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241204&amp;DB=EPODOC&amp;CC=EP&amp;NR=4469108A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241204&amp;DB=EPODOC&amp;CC=EP&amp;NR=4469108A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TROLLSAS, Olof Mikael</creatorcontrib><creatorcontrib>STANKUS, John J</creatorcontrib><creatorcontrib>GHOLAMI, Shahram Shawn</creatorcontrib><title>BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM</title><description>Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 15 and 1,000 Centipoise per unit area.</description><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</subject><subject>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</subject><subject>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB1cvXzdPdTCAjyDw5xDPF0VvCIDHANCvBxDPZ0VAgJcnUM8XX1C1EIjgwOcfXlYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmJmaWhgYWjobGRCgBAKEbJYM</recordid><startdate>20241204</startdate><enddate>20241204</enddate><creator>TROLLSAS, Olof Mikael</creator><creator>STANKUS, John J</creator><creator>GHOLAMI, Shahram Shawn</creator><scope>EVB</scope></search><sort><creationdate>20241204</creationdate><title>BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM</title><author>TROLLSAS, Olof Mikael ; STANKUS, John J ; GHOLAMI, Shahram Shawn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4469108A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</topic><topic>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</topic><topic>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><toplevel>online_resources</toplevel><creatorcontrib>TROLLSAS, Olof Mikael</creatorcontrib><creatorcontrib>STANKUS, John J</creatorcontrib><creatorcontrib>GHOLAMI, Shahram Shawn</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TROLLSAS, Olof Mikael</au><au>STANKUS, John J</au><au>GHOLAMI, Shahram Shawn</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM</title><date>2024-12-04</date><risdate>2024</risdate><abstract>Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 15 and 1,000 Centipoise per unit area.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4469108A1
source esp@cenet
subjects DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
title BENIGN PROSTATIC HYPERPLASIA TREATMENT SYSTEM
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A19%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TROLLSAS,%20Olof%20Mikael&rft.date=2024-12-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4469108A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true